Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor

Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor

US Patent 6534540 · Granted Mar 18, 2003

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-spalling combination on an impact tool with an improved holding system2015
Inexpensive fourth world primitive water cleanser with key parts transportable i2015
Direct visualization robotic intra-operative radiation therapy device with radia2014
Liposomally encapsulated reduced glutathione, including with other pharmacologic2014
Liposomally encapsulated reduced glutathione, including with other pharmacologic2014
Combination for passing an object through a three dimensional true color image2013
Liposomal formulation for oral administration of glutathione (reduced)2013
Liposome-encapsulated glutathione for oral administration2012
Liposome-encapsulated glutathione for oral administration2012
Systemic administration of NAC as an adjunct in the treatment of bioterror expos2012
Systemic administration of NAC as an adjunct in the treatment of bioterror expos2012
Direct visualization robotic intra-operative radiation therapy applicator device2012